Repligen Corporation reports results for the quarter ended September 30 - Earnings Summary

• Repligen Corporation reported quarterly adjusted earnings of 53 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 46 cents. The mean expectation of seventeen analysts for the quarter was for earnings of 46 cents per share. Wall Street expected results to range from 41 cents to 48 cents per share.

• Revenue rose 10.8% to $209.27 million from a year ago; analysts expected $206.62 million.

• Repligen Corporation's reported EPS for the quarter was a loss of 68 cents​.

• The company reported a quarterly loss of $38.43 million.

• Repligen Corporation shares had fallen by 6.3% this quarter and gained 10.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 1.7% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 17 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for Repligen Corporation is $200.00, about 9.9% above its last closing price of $180.17

This summary was machine generated from LSEG data October 27 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)